immune system

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

Tolerance inks $260M deal for thymus-targeting fusion protein

Tolerance Bio has vaulted into the clinic by agreeing to pay NeoImmuneTech up to $260 million for rights to a fusion protein.
Nick Paul Taylor Aug 19, 2026 10:00am
unknown arrows directions

Adaptive plots split of drug discovery and diagnostics arms

Jun 16, 2026 9:24am
Cash deal money payment

Lilly joins platform biotech's Repertoire with $1.9B deal

Jan 29, 2026 6:30am
money funding financing bank

Veteran venture capitalists launch autoimmune firm Vie Ventures

Jul 9, 2025 11:10am
A close-up view of a handshake between a doctor and a professional symbolizing agreement and business relations

GSK and Cambridge scientists join forces in $65M immune R&D deal

Oct 22, 2024 3:30pm
pay deal hand over cash licensing transaction money

BMS pays $65M to expand Repertoire of autoimmune assets

Apr 29, 2024 6:15am